Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Graham

Showing results (1021-1030 of 1,460) with videos related to

Pageof 146
Sort By:
Annals of Internal Medicine|August 15, 1996
Safety and immunogenicity of a candidate HIV-1 vaccine in healthy adults: recombinant glycoprotein (rgp) 120. A randomized, double-blind trial. NIAID AIDS Vaccine Evaluation GroupB S Graham, M C Keefer, M J McElrath, et al.
Health Promotion Journal of Australia : Official Journal of Australian Association of Health Promotion Professionals|September 4, 2024
'Our culture makes us strong': Understanding and working with community strengths among Aboriginal people in western SydneyK Gardner, S Graham, M Beadman, et al.
Annals of Internal Medicine|January 15, 1991
The safety and immunogenicity of a human immunodeficiency virus type 1 (HIV-1) recombinant gp160 candidate vaccine in humans. NIAID AIDS Vaccine Clinical Trials NetworkR Dolin, B S Graham, S B Greenberg, et al.
Molecular Genetics and Metabolism|May 2, 2017
The effect of galsulfase enzyme replacement therapy on the growth of patients with mucopolysaccharidosis VI (Maroteaux-Lamy syndrome)P Harmatz, C J Hendriksz, C Lampe, et al.
The American Journal of Gastroenterology|September 1, 1995
Variability with omeprazole-amoxicillin combinations for treatment of Helicobacter pylori infectionK S Graham, H Malaty, H M el-Zimaity, et al.
AIDS Research and Human Retroviruses|December 1, 1994
Studies of high doses of a human immunodeficiency virus type 1 recombinant glycoprotein 160 candidate vaccine in HIV type 1-seronegative humans. The AIDS Vaccine Clinical Trials NetworkM C Keefer, B S Graham, R B Belshe, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 22, 2004
Cyclooxygenase inhibition augments allergic inflammation through CD4-dependent, STAT6-independent mechanismsKoichi Hashimoto, James R Sheller, Jason D Morrow, et al.
Vaccines|March 1, 2019
Epitope-Specific Serological Assays for RSV: Conformation MattersEmily Phung, Lauren A Chang, Kaitlyn M Morabito, et al.
Tropical Medicine & International Health : TM & IH|May 21, 1998
A community randomized controlled trial of insecticide-treated bednets for the prevention of malaria and anaemia among primigravid women on the Kenyan coastC E Shulman, E K Dorman, A O Talisuna, et al.
Nature|March 4, 2016
Pre-fusion structure of a human coronavirus spike proteinRobert N Kirchdoerfer, Christopher A Cottrell, Nianshuang Wang, et al.
Pageof 146

Showing results (1021-1030 of 1,460) with videos related to

Sort By:
Pageof 146
Annals of Internal Medicine|August 15, 1996
Safety and immunogenicity of a candidate HIV-1 vaccine in healthy adults: recombinant glycoprotein (rgp) 120. A randomized, double-blind trial. NIAID AIDS Vaccine Evaluation GroupB S Graham, M C Keefer, M J McElrath, et al.
Health Promotion Journal of Australia : Official Journal of Australian Association of Health Promotion Professionals|September 4, 2024
'Our culture makes us strong': Understanding and working with community strengths among Aboriginal people in western SydneyK Gardner, S Graham, M Beadman, et al.
Annals of Internal Medicine|January 15, 1991
The safety and immunogenicity of a human immunodeficiency virus type 1 (HIV-1) recombinant gp160 candidate vaccine in humans. NIAID AIDS Vaccine Clinical Trials NetworkR Dolin, B S Graham, S B Greenberg, et al.
Molecular Genetics and Metabolism|May 2, 2017
The effect of galsulfase enzyme replacement therapy on the growth of patients with mucopolysaccharidosis VI (Maroteaux-Lamy syndrome)P Harmatz, C J Hendriksz, C Lampe, et al.
The American Journal of Gastroenterology|September 1, 1995
Variability with omeprazole-amoxicillin combinations for treatment of Helicobacter pylori infectionK S Graham, H Malaty, H M el-Zimaity, et al.
AIDS Research and Human Retroviruses|December 1, 1994
Studies of high doses of a human immunodeficiency virus type 1 recombinant glycoprotein 160 candidate vaccine in HIV type 1-seronegative humans. The AIDS Vaccine Clinical Trials NetworkM C Keefer, B S Graham, R B Belshe, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 22, 2004
Cyclooxygenase inhibition augments allergic inflammation through CD4-dependent, STAT6-independent mechanismsKoichi Hashimoto, James R Sheller, Jason D Morrow, et al.
Vaccines|March 1, 2019
Epitope-Specific Serological Assays for RSV: Conformation MattersEmily Phung, Lauren A Chang, Kaitlyn M Morabito, et al.
Tropical Medicine & International Health : TM & IH|May 21, 1998
A community randomized controlled trial of insecticide-treated bednets for the prevention of malaria and anaemia among primigravid women on the Kenyan coastC E Shulman, E K Dorman, A O Talisuna, et al.
Nature|March 4, 2016
Pre-fusion structure of a human coronavirus spike proteinRobert N Kirchdoerfer, Christopher A Cottrell, Nianshuang Wang, et al.
Pageof 146